GLP-1s have already reshaped healthcare and nutrition, and their ripple effect is now reaching the beauty industry, where patients are seeking targeted solutions like AV Laboratories' 360-degree molecular nourishment approach, powered by patented AVL SOM3 technology. “Rapid physical change can place new demands on the skin’s appearance, and new demands require a more intelligent skincare approach,” said Sylwia Pawlaczyk, COO and Master Formulator at AV Laboratories. “AVL SOM3 was developed to help support the skin’s natural renewal environment with molecular building blocks associated with healthier-looking skin over time.”
Renewing, restoring, and rejuvenating AVL SOM3 is at the center of AV Laboratories' Face Serum and Face Cream Light, formulated to address not only facial fat loss but also fibroblast signalling, collagen metabolism, hormonal balance, and cellular energy.
What Makes This Trend Stand Out
- GLP-1 Beauty
- Weight-loss medication users represent a fast-emerging skincare audience with needs tied to facial volume changes, elasticity, and visible rejuvenation.
- Molecular Skincare
- Patented ingredient systems that target cellular energy, collagen metabolism, and fibroblast signaling are shifting beauty products toward biotech-backed performance claims.
- Post-weight-loss Care
- Rapid body transformation is creating demand for targeted personal care routines that bridge nutrition, dermatology, and aesthetic maintenance.
Sectors Adopting This
- Skincare
- Advanced formulations designed around metabolic and hormonal skin changes are expanding premium product categories beyond traditional hydration and anti-aging.
- Aesthetic Medicine
- Clinics serving GLP-1 patients are becoming natural channels for adjunct skincare solutions that complement injectables, fillers, and facial contouring services.
- Nutraceuticals
- The convergence of internal nourishment and topical molecular support is opening space for beauty systems that connect supplementation, metabolism, and skin renewal.
